FR3001130A1 - Composition, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises an oil phase, a merocyanine compound, and an insoluble organic UV filter in a medium - Google Patents

Abstract

Cosmetic or dermatological composition comprises, in a medium, (a) at least one oil phase, (b) at least one merocyanine compound (I), and (c) at least one insoluble organic UV filter. Cosmetic or dermatological composition comprises, in a medium, (a) at least one oil phase, (b) at least one merocyanine compound of formula (I) and their E/E- or E/Z- geometrical isomer forms, and (c) at least one at least one insoluble organic UV filter. R : 1-22C-alkyl, 2-22C-alkenyl, 2-22C-alkynyl, 3-22C-cycloalkyl or 3-22C-cycloalkenyl (all optionally interrupted with one or more O). [Image] ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.

Description

Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic UV filter The present invention relates to a cosmetic or dermatological composition comprising in a physiologically acceptable support: a) at least one oily phase and b) at least one merocyanine compound of formula (1) defined further and c) at least one insoluble organic UV filter.

The present invention also relates to a non-therapeutic cosmetic process for the care and / or makeup of a keratinous material comprising the application on the surface of said keratinous material of at least one composition according to the invention as defined above. .

It also relates to a non-therapeutic cosmetic process for limiting the darkening of the skin and / or improving the color and / or the homogeneity of the complexion, comprising the application to the surface of the keratinous material of at least one composition such that previously defined.

It also relates to a non-therapeutic cosmetic method for preventing and / or treating the signs of aging of a keratinous material comprising the application to the surface of the keratinous material of at least one composition as defined above.

It is known that radiations of wavelength between 280 nm and 400 nm allow tanning of the human epidermis and that radiation of wavelength between 280 and 320 nm, known as UV-rays. B interfere with the development of the natural tan. Exposure is also likely to induce an alteration of the biomechanical properties of the epidermis which results in the appearance of wrinkles leading to premature aging of the skin. It is also known that UV-A rays of wavelengths between 320 and 400 nm penetrate deeper into the skin than UV-B rays. UV-A rays cause immediate and persistent browning of the skin. Daily exposure to UVA rays, even for short periods of time, under normal conditions can lead to degradation of collagen and elastin fibers which results in a modification of the micro-relief of the skin, the appearance of wrinkles and irregular pigmentation (brown spots, heterogeneity of complexion).

Protection against UVA and UVB radiation is therefore necessary. An effective photoprotection product must protect both UVA and UVB radiation.

Many photoprotective compositions have been proposed to date to remedy the effects induced by UVA and / or UVB radiation. They usually contain organic UV filters and / or inorganic UV filters which function according to their own chemical nature and their own properties by absorption, reflection, or diffusion of UV radiation. They generally contain mixtures of liposoluble organic filters and / or water-soluble UV filters associated with metal oxide pigments such as titanium dioxide or zinc oxide. Numerous cosmetic compositions intended to limit the darkening of the skin, to improve the color and the homogeneity of the complexion have been proposed to date. It is well known in the field of solar products that such compositions can be obtained using UV filters, and in particular UVB filters. Some compositions may also contain UVA filters. This filter system must cover the UVB protection in order to limit and control the neo-synthesis of melanin favoring the global pigmentation, but must also cover the UVA protection in order to limit and control the oxidation of the existing melanin leading to the darkening of the skin color. However, it is extremely difficult to find a composition which contains a particular combination of UV filters which would be especially suited to improving the quality of the skin both in terms of color and its mechanical elasticity properties. This improvement is particularly sought after on already pigmented skin so as not to increase the pigment load in melanin or the structure of melanin already present in the skin.

In fact, the majority of organic systems filtering UVA and UVB radiation consist of aromatic compounds absorbing in the wavelength range between 280 and 370 nm. In addition to their filtering ability of solar radiation, the desired photo-protection compounds must also have good cosmetic properties, good solubility in the usual solvents and in particular in fatty substances such as oils, fats, as well as good photo-stability. They must also be colorless or at least present a color cosmetically acceptable to the consumer.

One of the main disadvantages known to date of these solar compositions is that their UVA and UVB radiation filtering systems have insufficient efficiency against UV radiation and particularly against long UVA radiation with wavelengths above 370 nm, in the goal of controlling the photoinduced pigmentation and its evolution by a system filtering the UV on the whole spectrum UV. In this respect, a particularly interesting family of UV-A filters currently consists of the dibenzoylmethane derivatives, and in particular 4-tert-butyl-4'-methoxydibenzoylmethane, which in fact have a high intrinsic absorption capacity. These dibenzoylmethane derivatives, which are now products that are well known per se as active filters in UV-A, are described in particular in French patent applications FR-A-2326405 and FR-A-2440933, as well as in US Pat. European Patent Application EP-A-0114607; 4-tert-butyl-4'-methoxydibenzoyl methane is also currently offered for sale under the trade name "PARSOL 1789®" by the company DSM Nutritional Products. These compounds are however photo-unstable and do not allow associated UVB filters to largely protect UV on the 280 to 400nm range. Indeed UVA and UVB filter systems thus formed can protect from 280nm to 370nm, at best 380nm at high levels. They also have the disadvantage of having to be solubilized in high oil levels, which often leads to formulation difficulties as well as sensory disadvantages in formula, such as a greasy effect on application. The organic insoluble filters then appear to be particularly advantageous since they can be dispersed in water and introduced directly into the aqueous phase. Those known in particular in US5869030 are particularly known.

Among these filters, there may be mentioned particularly Methylene bis-Benzotriazolyl Tetramethylbutylphenol, sold in solid form under the trade name "MIXXIM BB / 100®" by FAIRMOUNT CHEMICAL or in micronized form in aqueous dispersion under the trade name "TINOSORB M ®" by BASF. This UV filter absorbs both UVA radiation and UVB radiation.

UVA and UVB filter systems described in this US5869030 patent including the UVB filter and UVA Methylene bis-Benzotriazolyl Tetramethylbutylphenol do not, however, largely protect UV range 280 to 400nm including having an observable absorbance up to the length of 400 nm wave included. US Pat. No. 4,195,999 discloses the application WO2004 / 006878, the document IP COM Journal 4 (4), No. IPCOM000011179D published on March 4, 2004, an interesting family of lipophilic merocyanine derivatives, in particular the compound Octy1-5- N, N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate corresponding to compound MC172 of structure 0 LN which make it possible to filter long UVA radiation with wavelengths above 370 nm. However, the UVA and UVB filter systems consisting of these merocyanine filters and lipophilic filters such as benzotriazole-functional silicones still do not make it possible to protect UVs in the 280 to 400 nm range, in particular by obtaining an observable absorbance up to the length of the film. 400 nm wave included.

In order to search for other merocyanines which make it possible to achieve this objective, unpublished PCT / EP2012 / 064195 have been proposed for merocyanines comprising polar groups consisting of hydroxyl functions and ethers which show good filtration efficiency. long UVA.

During her research, the Applicant has noticed that some of these merocyanines associated with insoluble organic filters do not allow to maintain the overall protection of UV radiation from 290 to 400 nm in particular to obtain an observable absorbance up to the length of 400 nm wave included.

There remains therefore the need to find a new UVA and UVB filter system based on insoluble organic filter which is photostable and which guarantees a global protection of UV radiation from 280 to 400 nm including having a significant absorbance up to the wavelength 400 nm included.

The Applicant has surprisingly discovered that this objective could be achieved by using at least one organic insoluble filter and a particular merocyanine of formula (1) which will be defined later in detail.

Thus, according to one of the objects of the present invention, it is now proposed a cosmetic or dermatological composition comprising in a physiologically acceptable carrier: a) at least one oily phase and b) at least one merocyanine compound of formula (1) defined below and c) at least one organic insoluble filter. The present invention also relates to a non-therapeutic cosmetic process for the care and / or makeup of a keratinous material comprising the application on the surface of said keratinous material of at least one composition according to the invention as defined above. . It also relates to a non-therapeutic cosmetic process for limiting the darkening of the skin and / or improving the color and / or the homogeneity of the complexion, comprising the application to the surface of the keratinous material of at least one composition as defined above . It also relates to a non-therapeutic cosmetic method for preventing and / or treating the signs of aging of a keratinous material comprising the application to the surface of the keratinous material of at least one composition as defined above.

Other features, aspects and advantages of the invention will appear on reading the detailed description which follows. By "human keratin materials" is meant the skin (body, face, eye area), hair, eyelashes, eyebrows, hair, nails, lips, mucous membranes. By "physiologically acceptable" is meant compatible with the skin and / or its integuments, which has a pleasant color, smell and feel and which does not generate unacceptable discomfort (tingling, tightness, redness), which can divert the consumer to use this composition. By "insoluble UV filter" is meant any organic or inorganic cosmetic or dermatological compound filtering UV radiation having a solubility in water of less than 0.5% by weight and a solubility of less than 0.5% by weight in most organic solvents such as paraffin oil, fatty alcohol benzoates and triglycerides of fatty acids, for example Miglyol® 812 sold by the company DYNAMIT NOBEL. This solubility, performed at 70 ° C is defined as the amount of product in solution in the equilibrium solvent with an excess of suspended solid after return to room temperature.

It can easily be evaluated in the laboratory. By "between X and Y" is meant the range of values also including the X and Y terminals.

By "prevention" or "prevention" is meant according to the invention the fact of reducing the risk of occurrence or slowing down the occurrence of a given phenomenon, namely, according to the present invention, the signs of the aging of a material keratin. MEROCYANINES According to the present invention, the merocyanine compounds according to the invention correspond to the following formula (1) as well as their isomeric E / E- or E / Z-: (1) H geometrical forms in which R is an alkyl group. C1-C22, a C2-C22 alkenyl group, a C2-C22 alkinyl group, a C3-C22 cycloalkyl group or a C3-C22 cycloalkenyl group, said groups being capable of being interrupted by one or more O. The merocyanine compounds of the invention may be in their geometric isomeric forms E / E-, E / Z-. The compounds of formula (1) are those in which: R is a C 1 -C 22 alkyl which may be interrupted by one or more O.

Among the compounds of formula (1), use will be made more particularly of those selected from the following compounds as well as their isomeric geometrical forms E / E-, E / Z-: 1 o 0 H 4 I ON No. 0 0 (:) ethyl (2Z) -cyano {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanoate. N, N-butoxyethyl (2Z) -cyano [(3-methoxypropyl) amino] cyclohex-2-en-ylidenelethanoate 2 O 0 .-. 0. 5 (bo oo HH. ..) NN 2-ethoxyethyl (2Z) -cyano {3 - [(3-methoxypropyl (2Z) -cyano {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanoate methoxypropyl) amino] cyclohex-2-en-1-ene N-N-methylpropyl (2Z) -cyano {3 - [(3-ethoxypropyl (2Z) -cyano] ylidenelethanoate ## STR1 ## Methylpropyl (N-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanoate (III) -N-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanoate According to a more particularly preferred embodiment of the invention, the 2-ethoxyethyl compound will be used. (2Z) -cyano {3 - [(3-methoxypropyl) amino] cyclohex-2 -en-1-ylidene} ethanoate (2) in its geometric E / Z configuration of the following structure: H and / or in its geometric E / E configuration of the following structure: ## STR5 ## The merocyanines of formula (1) according to US Pat. invention, are preferably present in the compositions according to the invention in a concentration ranging from 0.1% to 10% by weight, and preferably from 0.2% to 5% by weight relative to the total weight of the composition. The compounds of formula (1) can be prepared according to the protocols described in Pat. Apt. WO 2007/071582, in IP.com Journal (2009), 9 (5A), 29-30 IPCOM000182396D under the title "Process for producing 3-amino-2-cyclohexan-1-ylidene compounds" and in US-A-4,749,643 neck, 13, line 66 - col. 14, line 57 and the references cited in this regard. ORGANIC INSOLUBLE UV FILTER The insoluble organic UV filters according to the invention preferably have an average particle size which varies from 0.01 to 5 μm and more preferably from 0.01 to 2 μm and more particularly from 0.020 to 2 μm.

The average particle diameter was measured by a Cutter N4 PLUS type particle size distribution analyzer manufactured by Bechman Coulter Inc. The insoluble organic filters according to the invention can be brought into the desired particulate form by any ad-hoc means such as in particular dry milling or in a solvent medium, sieving, atomization, micronisation, spraying. The insoluble organic filters according to the invention in micronized form can in particular be obtained by a method of grinding an insoluble organic UV filter in the form of coarse particles in the presence of a suitable surfactant for improving the dispersion. particles thus obtained in cosmetic formulations.

An example of a process for micronizing insoluble organic filters is described in GB-A-2 303 549 and EP-A-893119. The grinding apparatus used according to these documents may be a jet mill, ball mill, vibration mill or hammer mill and preferably a high speed grinding mill or an impact mill and more particularly a rotary ball mill, a vibrating mill, tube mill or rod mill. According to this particular process, the alkylpolyglucosides of the structure CnH2r1-0O (C61-11005) xH in which n is an integer of 8 to 16 are used as surfactants for the grinding of said filters, and x is the average degree of polymerization of the unit (C6H1005) and varies from 1.4 to 1.6. They can be chosen from C1-C12 esters of a compound of structure CnH2n-F1 0 (C61-11005) xH and more precisely an ester obtained by reaction of a C1-C12 carboxylic acid such as formic acid , acetic, propionic, butyric, sulfosuccinic, citric or tartaric with one or more free OH functions on the glucoside unit (C6H1005). As alkylpolyglucoside, mention may be made in particular of decylglucoside. Said surfactants are generally used at a concentration of from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the insoluble filter in its micronized form. The insoluble organic UV filters in accordance with the invention may be chosen especially from organic UV filters of the oxalanilide type, of the triazine type, of the benzotriazole type; vinyl amide type; of the cinnamide type; of the type comprising one or more benzazole and / or benzofuran, benzothiophene or indole groups; aryl vinylene ketone type; phenylene bis-benzoxazinone derivative type, amide derivative type, sulfonamide or acrylonitrile carbamate or mixtures thereof. As used in the present invention, the term benzazole includes both benzothiazoles, benzoxazoles and benzimidazoles. Among the UV filters of the oxalanilide type in accordance with the invention, mention may be made of those having the structure: ## STR2 ## in which T1, T'1, T2 and T'2 denote identical and different, a C1-C8 alkyl radical or a C1-C8 alkoxy radical. These compounds are described in patent application WO95 / 22959.

By way of examples, mention may be made of the commercial products TINUVIN 315® and TIN UVIN 312® sold by the company BASF and of structure, respectively: CH, B / Triazines Among the insoluble UV-type filters of the triazine type according to the invention, mention may also be made of those having the following formula (II): wherein T3, T4, T5, independently, are phenyl, phenoxy, pyrrolo, in which phenyl, phenoxy, pyrrolo unsubstituted or substituted by one, two or three substituents selected from OH, C1-C18alkyl or C1-C18alkoxy, C1-Ciscarboxyalkyl, C5-C8cycloalkyl, a methylbenzylidenecamphor group, a group - (CH = CH) n (CO) -OT8, with T6 being C1- C1-8alkyl is cinnamyl.

These compounds are described in WO 97/03642, GB 2286774, EP-743309, WO 98/22447, GB 2319523. Among the UV triazine type filters according to the invention, mention may also be made of the insoluble derivatives of s-triazine. bearing benzalmalonate and / or phenylcyanoacrylate groups such as those described in EP-A-0790243 (forming an integral part of the content of the description). Among these insoluble UV screening agents of the triazine type, mention will be made more particularly of the following compounds: 2,4,6-tris (diethyl 4'-aminobenzalmalonate) -s-triazine, 0C2H, 0 NH N - 2,4 6,6-tris (4'-amino benzalmalonate diisopropyl) -s-triazine, 2,4,6-tris (4'-amino dimethyl benzalmalonate) -s-triazine, 2,4,6-tris (α-cyano-4-aminocinnamate ethyl) -s-triazine.

Among the triazine type UV filters in accordance with the invention, mention may also be made of the insoluble s-triazine derivatives bearing benzotriazole and / or benzothiazole groups such as those described in the application WO98 / 25922 (forming an integral part of the content of the description).

Among these compounds, mention may be made more particularly of: 2,4,6-tris [(3'-benzotriazol-2-yl-2'-hydroxy-5'-methyl) phenylamino] -s-triazine, -2; 4,6-tris [(3'-benzotriazol-2-yl-2'-hydroxy-5'-ter-octyl) phenylamino] -s-triazine. There may also be mentioned the symmetrical triazines substituted by naphthalenyl groups or polyphenyl groups described in US Pat. No. 6,225,467, WO2004 / 085412 (see compounds 6 and 9) or the "Symetrical Triazine Derivatives" IP.COM Journal, IP document. .COM INC. WEST HENRIETTA, NY, US (September 20, 2004) in particular 2,4,6-tris (di-phenyl) -triazine and 2,4,6-tris (terphenyl) -triazine which is included in the applications W006 / 035000, W006 / 034982, W006 / 034991, W006 / 035007, WO2006 / 034992, WO2006 / 034985. C / Benzotriazoles Among the insoluble organic UV-screening agents of the benzotriazole type in accordance with the invention, mention may be made of those of the following formula (III) as described in the application WO95 / 22959 (forming an integral part of the content of the description): in which T7 denotes a hydrogen atom or a C1-C18 alkyl radical; T8 and T9, identical or different, denote a C 1 -C 18 alkyl radical optionally substituted with a phenyl. By way of example of compounds of formula (III), mention may be made of the commercial products TINUVIN 328, 320, 234 and 350 of the BASF Company with the following structure: C (CH 3), CH 2 CH 3 C (CH 3) 2 CH 2 CH 3 C (CH 3) 3 C (CH 3) 3 HO C (CH 3) 2 C (CH 3) 2 CH 3 CH-C 2 H 5 C (CH 3) 3 Among the insoluble organic UV screening agents of the benzotriazole type in accordance with the invention, mention may be made of the compounds as described in US 5,687,521, US 5,687,521, US 5,373,037, US 5,362,881 and in particular [2,4'-dihydroxy-3- (2H-benzotriazol-2-yl) -5- (1,1,3 , 3-tetramethylbutyl) -2'-n-octoxy-5'-benzoyl] diphenylmethane sold under the name MIXXIM PB30® by the company FAIRMOUNT CHEMICAL of structure: OH CH2 tertC, H.7 Among the insoluble organic UV filters of the benzotriazole type According to the invention, mention may be made of methylene bis (hydroxyphenyl benzotriazole) derivatives having the following structure: CH 2 (IV) 10 11 in which the radicals T 10 and T 11, which may be identical or different, denote a Ci-C alkyl radical 18 may be substituted by one or more radicals selected from C1-C4 alkyl, C5-C12 cycloalkyl or aryl residue. These compounds are known per se and described in the applications US Pat. No. 5,237,071, US 5,166,355, GB-A-2,303,549, DE 197,246 and EP-A-893,119 (forming an integral part of the description). In the formula (I) defined above: the alkyl groups C1-C18 may be linear or branched and are for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, tert-octyl, n -amyl, n-hexyl, n-heptyl, n-octyl, isooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, tetradecyl, hexydecyl, or octadecyl; C 5 -C 12 cycloalkyl groups are, for example, cyclopentyl, cyclohexyl, cyclooctyl; aryl groups are for example phenyl, benzyl.

Among the compounds of formula (IV), there may be mentioned those of the following structure: OH CH, compound (a) compound (b) compound (c) Compound (a) of nomenclature 2,2'-methylene-bis- [6 - (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol] is sold in particular under the trade name MIXXIM BB / 200® by the company Fairmount Chemical. The compound (c) of 2,2'-methylene-bis- [6- (2H-benzotriazol-2-yl) -4- (methyl) phenol] is sold in particular in solid form under the trade name MIXXIM BB / 200. ® by FAIRMOUNT CHEMICAL.

D / Vinyl Amides Among the insoluble organic vinylidide type filters, there may be mentioned, for example, the compounds of the following formulas which are described in the application WO95 / 22959 (forming an integral part of the content of the description): T12- (Y) rC (= O) -C (T13) = C (T14) -N (T15) (T16) (V) in which T12 is a C1-C18 alkyl radical, preferably C1-C5 alkyl, or a phenyl group optionally substituted with one, two or three radicals selected from OH, C1-C18 alkyl, C1-C8 alkoxy, or -C (= O) -OT17 group where T17 is C1-C18 alkyl; T13, T14, T15 and T16, which may be identical or different, denote a C1-C18 alkyl radical, preferably a C1-C5 alkyl radical, or a hydrogen atom; Y is N or O and r is 0 or 1. Among these compounds, mention will be made more particularly of: 4-octylamino-3-penten-2-one; ethyl-3-octylamino-2-butenoate; 3-octylamino-1-phenyl-2-buten-1-one - 3-dodecylamino-1-phenyl-2-buten-1-one. E / Cinnamam ides Among the insoluble organic cinnamamide type filters in accordance with the invention, mention may also be made of the compounds as described in the application WO95 / 22959 (forming an integral part of the content of the description) and corresponding to the following structure: in which OT18 is a hydroxy or C1-C4 alkoxy radical, preferably methoxy or ethoxy; T19 is hydrogen, C1-C4 alkyl, preferably methyl or ethyl; T20 is a - (CONH) s-phenyl group or s is 0 or 1 and the phenyl group may be substituted with one, two or three groups selected from OH, C1-C18 alkyl, C1-C8 alkoxy, or a group -C (= O) -OT21 wherein T21 is C1-C18 alkyl and more preferably T21 is phenyl, 4-methoxyphenyl or phenylamocarocarbonyl. Mention may also be made of cinnamamide dimers such as those described in US Pat. No. 5,888,481, for example the compound of structure: ## STR2 ## Among the benzazole-type insoluble organic screening agents, mention may be made of those corresponding to one of the following formulas: (A) pn (R1) wherein each of X is independently oxygen or sulfur or NR2, each of Z is independently N or CH, each of R1 is independently an OH group, a halogen atom, a linear or branched C 1-8 alkyl group, optionally containing a silicon atom, or a linear or branched C 1-8 alkoxy group, each of the numbers m is independently 0, 1 or 2, n is an integer from 1 to 4 inclusive, p is 0 or 1, each of the numbers q is independently 0 or 1, each of R2 is independently hydrogen , a linear or branched C 1 -C 8 alkyl or benzyl group, optionally containing a silicon atom, A represents a radical of valence n chosen from those of formulas: (m) (n) in which each of the symbols R 3 represents independently a halogen atom or a linear or branched C1-4 alkyl or alkoxy group, or hydroxy, R4 represents a hydrogen atom or a linear or branched C1-4 alkyl group, c = 0-4, d = 0 - 3, e = 0 or 1, and f = 0-2. These compounds are described in particular in DE 676 103 and CH 350 763, US Pat. No. 5,501,850, US Pat. No. 5,961,960, US Pat. EP0669323, US Patent 5,518,713, US Patent 2,463,264, J. Am.

Chem. Soc., 79, 5706-5708, 1957, the article of J. Am. Chem. Soc., 82, 609-5119, 1960, patent application EP0921126, patent application EP712855. As examples of preferred compounds of formula (VII) of the family of 2-arylbenzazoles, there may be mentioned 2-benzoxazol-2-yl-4-methylphenol, 2- (1H-benzimidazol-2-yl) 4-methoxyphenol or 2-benzothiazol-2-ylphenol, these compounds can be prepared for example according to the methods described in patent CH 350 763. As examples of preferred compounds of formula (VII) of the family of benzimidazolylbenzazoles 2,2'-bis-benzimidazole, 5,5 ', 6,6'-tetramethyl-2,2'-bis-benzimidazole, 5,5'-dimethyl-2,2'-bis benzimidazole, 6-methoxy-2,2'-bis-benzimidazole, 2- (1H-benzimidazol-2-yl) benzothiazole, 2- (1H-benzimidazol-2-yl) -benzoxazole and N, N'-dimethyl-2,2'-bis-benzimidazole, these compounds can be prepared according to the procedures described in US Pat. Nos. 5,961,960 and 2,463,264. (a) (b) (c) (d) N R 4 R 3) f (R 3) e (k) (g) By way of examples of preferred compounds of formula (VII) of the family of Examples of phenylene benzazoles are 1,4-phenylenebis (2-benzoxazolyl), 1,4-phenylenebis (2-benzimidazolyl), and 1,3-phenylenebis (2-benzoxazolyl). ), 1,2-phenylene-bis- (2-benzoxazolyl), 1,2-phenylene-bis (benzimidazolyl), 1,4-phenylenebis (N-2-ethylhexyl) -2-benzimidazolyl ) and 1,4-phenylene-bis (N-trimethylsilylmethyl-2-benzimidazolyl), these compounds can be prepared according to the procedures described in US Patent 2,463,264 and in J. Am. Chem. Soc., 82, 609 (1960) and J. Am. Chem. Soc., 79, 5706 5708 (1957).

By way of examples of preferred compounds of formula (VII) of the benzofuranyl-benzoxazole family, mention will be made of 2- (2-benzofuranyl) -benzoxazole, 2- (benzofuranyl) -5-methylbenzoxazole and 2- (3-benzofuranyl) benzoxazoles. Methyl-2-benzofuranyl) benzoxazole, these compounds can be prepared according to the procedures described in US Pat. No. 5,518,713. Preferred compounds of formula (VIII) include, for example, 2,6-diphenyl-1. 7-dihydro-benzo [1,2-d; 4,5-dl-di-imidazole corresponding to the formula NH NH or 2,6-distyryl-1,7-dihydro-benzo [1,2-d; 4,5-d1-diimidazole or 2,6-di (p-tert-butylstyryl) -1,7-dihydrobenzo [1,2-d; which can be prepared according to the application EP 0 669 323.

As a preferred compound of formula (IX), mention may be made of 5,5'-bis - [(phenyl-2) -benzimidazole] of formula: H H, the preparation of which is described in J. Chim. Phys., 64, 1602 (1967).

Of these insoluble organic compounds which filter UV radiation, 2- (1H-benzimidazol-2-yl) benzoxazole, 5ole, 6-methoxy2,2'-bis-benzimidazole, 2- (1H-benzimidazole) are particularly preferred. -2-yl) -benzothiazole, 1,4-phenylenebis- (2-benzoxazolyl), 1,4-phenylene-bis (2-benzimidazolyl), 1,3-phenylenebis (2-benzoxazolyl), 1,2-phenylenebis (2-benzoxazolyl), 1,2-phenylenebis (2-benzimidazolyl) and 1,4-phenylenebis (N-trimethylsilylmethyl-2-benzimidazolyl) .40 G / Aryl vinylene ketones Among the insoluble organic filters of the aryl vinylene ketone type, mention may be made of those corresponding to one of the following formulas (X) and (XI): R6 R7 (X) R5 (XI) in which: n '= 1 or 2, B, in the formula (X) when n '= 1 or in the formula (XI), is an aryl radical selected from the following formulas (a') to (d '), or in the formula (X) when n '= 2, is a radical chosen from the following formulas (e') to (h '): (d') (&) (f) (g ') (h) in which: each of the symbols R8 independently represents an OH group, a halogen atom, a linear or branched C1-6 alkyl group and optionally containing a silicon atom, a linear C1-6 alkoxy group; or branched and optionally containing a silicon atom, a linear or branched C1-5 alkoxycarbonyl group, or a linear or branched C1-6 alkylsulfonamide group and optionally containing a silicon atom or an amino acid function, represents an integer between 0 and 4 inclusive, q 'represents 0 or 1, R5 represents hydrogen or an OH group, R6 represents hydrogen, a C1-6 alkyl group, linear or branched and optionally containing an atom silicon, a cyano group, a C 1-6 alkylsulfonyl group, a phenylsulfonyl group, R 7 represents a linear or branched C 1-6 alkyl group and optionally containing a silicon atom or a phenyl group which may form a and optionally substituted with one or two radicals R4, OR R6 and R7 together form a C2-10 hydrocarbon radical monocyclic, bicyclic or tricylic, optionally interrupted by one or more atoms of nitrogen, sulfur and oxygen and which may contain another carbonyl, and optionally substituted with a linear or branched C1-C8 alkylsulfonamide group, and optionally containing a silicon atom or an amino acid function; provided that when n '= 1, R6 and R7 do not form a camphor ring. By way of examples of compounds of formula (X) in which n '= 1, insoluble, filtering UV radiation, having an average particle size of between 10 nm and 5 nm, the following families may be mentioned: the compounds styryl ketone type as described in the application JP 04 134 042 such as 1- (3,4-dimethoxy-phenyl) -4,4-dimethyl-pent-1-en-3-one: MeO OMe - the compounds of the benzylidene cineole type such as those described in the article by E. Mariani et al., 16th IFSCC Congress, New York (1990)) such as 1,3,3-trimethyl-5- (4-methoxy-benzylidene) -2 oxa-bicyclo [2.2.2] octan-6-one: oo OMe - compounds of the benzylidene chromanone type such as those described in patent application JP 04 134 043 such as 3- (4-methoxy-benzylidene) -2,3 , 4a, 8-tetrahydro-chromen-4-one: OSO OMe - compounds of the benzylidene thiochromanone type such as those described in patent application JP 04 134 043 such as 3- (4-methoxy-benzylidene) -2,3,4a, 8-tetrahydro -chromen-4-thione: S OMe - compounds of the benzylidene quinuclidinone type such as those described in application EP 0 576 974 such as 4-methoxybenzylidene-1-azabicyclo [2.2.2] octan-3-one: OMe - compounds of the benzylidene cycloalcanone type such as those described in application FR 2,395,023, such as 2- (4-methoxy-benzylidene) -cyclopentanone and 2- (4-methoxy-benzylidene) -cyclohexanone: MeO MeO - compounds of the benzylidene hydantoin type such as those described in the application JP 01 158 090 such as 5- (3,4-dimethoxy-benzylidene) -imidazolidine-2,4-dione: MeO MeO - compounds of the benzylidene indanone type such as those described in patent application JP 04 134 043 as the 2 (4-methoxy-benzylidene) -indan-1-one: OMe - benzylidene tetralone compounds such as those described in patent application JP 04 134 043 such as 2- (4-methoxy-benzylidene) -3,4- Dihydro-2H-naphthalen-1-one: OMe - compounds of the benzylidene furanone type such as those described in EP 0 390 683 c such as 4- (4-methoxy-benzylidene) -2,2,5,5-tetramethyldihydro-furan-3-one: Me - compounds of the benzylidene benzofuranone type such as those described in the application JP 04 134 041 as the 2 benzylidene-benzofuran-3-one: compounds of the benzylidene indanedione type such as 2- (3,5-di-tert-butyl-4-hydroxy-benzylidene) indan-1,3-dione; benzylidene benzothiofuranone type such as those described in application JP 04,134,043) such as 2-benzylidene-benzo [b] thiophen-3-one: - benzylidene barbiturate type compounds such as 5- (4-methoxybenzylidene) -1,3 -dimethyl-pyrimidine-2,4,6-trione: benzylidene pyrazolone compounds such as 4- (4-methoxybenzylidene) -5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one Benzylidene imidazolone compounds such as 5- (4-methoxybenzylidene) -2-phenyl-3,5-dihydroimidazol-4-one: MeO - chalcone compounds such as 2-hydroxy-4-methoxy-phenyl) -3-phenyl-pro pennone: benzylidene compounds as described in FR 2,506,156 such as 3-hydroxy-1- (2-hydroxy-4-methoxy-phenyl) -3-phenyl-propenone: As examples of compounds of formula (X) in which n '= 2 insoluble, filtering UV radiation, having an average particle size between 10 nm and 5 pm, may be mentioned the following families: - phenylene compounds bis methylidene-nor- camphor as described in EP 0 693 471 such as 1,4-phenylene-bis (3-methylidenebicyclo [2.2.1] heptan-2-one): - phenylene bis methylidene camphor compounds as described in US Pat. FR 2,528,420 such as 1,4-phenylene-bis (3-methylidene-1,7,7-trimethyl-bicyclo [2.2.1] heptan-2-one) or 1,3-phenylene- bis- {3-methylidene-1,7,7-trimethyl-bicyclo [2.2.1] heptan-2-one}: the compounds of the phenylene bis methylidene camphor sulfonamide type such as those described in document FR 529 887; such as 1,4-phenylene-bis-3,3'-methylidene camphor-10,10-sulfonamide of ethyl or 2-ethylhexyl: and where I - and Ti - the compounds of the phenylene bis methylidene cineole type such as described in E. Mariani et al., 16th IFSCC Congress, New York (1990) as 1,4-phenylene-bis- {5-methylidene-3,3-dimethyl-2-oxa-bicyclo [2.2.2]. ] octan-6-one}: the compounds of the phenylene bis-methylidene ketotricyclodecane type as described in patent application EP 0 694 521, 1,4-phenylene-bis (octahydro) -7-methano-6-indene-5- one): - phenylene bisalkylene ketone compounds such as those described in patent application JP 04 134 041 such as 1,4-phenylene-bis- (4,4-dimethyl-pent-1-en-3-one): 1 - the compounds of the phenylene bis methylidene furanone type as described in application FR 2,638,354, such as 1,4-phenylenebis (4-methylidene-2,2,5,5-tetramethyl-dihydrofuran-3-one ): - the compounds of the phenylene bis methylidene type qu inuclidinone such as those described in application EP 0 714 880 such as 1,4-phenylene-bis- {2-methylidene-1-aza-bicyclo [2.2.2] octan-3-one}: as compounds of formula (XI), mention may be made of the following families: compounds of the bis benzylidene cycloalkanone type such as 2,5-dibenzylidene-cyclopentanone; gamma-pyrone type compounds as described in document JP 04 290 882; 6-bis (3,4-dimethoxy-phenyl) -pyran-4-one: Among these insoluble organic compounds which filter UV radiation of the aryl vinylene ketone type, the compounds of formula (X) in which n is particularly preferred are '= 2.

H / Phenylene bis-benzoxazinones Among the insoluble organic phenylene bis-benzoxazinone type screening agents, mention may be made of those corresponding to the following formula (XII): (XII) [1 with R representing a divalent aromatic radical chosen from formulas (e) (h) following: ') in which: each of the symbols R9 independently represents an OH group, a halogen atom, a linear or branched C1-6 alkyl group and optionally containing a silicon atom, a lower alkoxy group, C1-6, linear or branched and optionally containing a silicon atom, a C1-5 alkoxycarbonyl group, linear or branched, or a C1-6 alkylsulfonamide group, linear or branched and optionally containing a silicon atom or an amino acid function , p "represents an integer between 0 and 4 inclusive, q" represents 0 or 1, by way of examples of compounds of formula (XII), insoluble, filtering the UV radiation, having an average size of particles co Between 10 nm and 5 pm, mention may be made of the following derivatives: 2,2'-p-phenylene bis (3,1-benzoxazin-4-one), a CYASORB UV-3638® commercial product from CYTEC, 2,2 '- (4,4'-biphenylene) bis (3,1-benzoxazin-4-one), 2,2' - (2,6-naphthylene) bis (3,1-benzoxazin) 4-one). I-Derivatives amide, sulfonamide or acrylonitrile carbamate Among the insoluble organic filters of the amide, sulfonamide or acrylonitrile carbamate derivative type, those of formula (XIII) below: is a linear or branched C1-C8 alkyl group, n "'is 0, 1 or 2, X2 is a divalent radical of the formula - (C = O) -R11- (C = O) -, -SO2-R11 -SO2- or - (C = O) -O-R11-0- (C = O) -, Y represents a radical - (C = O) -R12 or -SO2R13, R11 represents a single bond or a divalent alkylene radical C1-C30 or linear or branched C3-C30 alkenylene, which may carry one or more hydroxyl substituents and may contain, in the carbon chain, one or more heteroatoms chosen from oxygen, nitrogen and silicon atoms, R12 represents a radical -OR14 or -NHR14, R13 represents a linear or branched C1-C30 alkyl radical, or a phenyl nucleus which is unsubstituted or substituted by radicals al. C1-C4 alkyl or alkoxy, R14 represents a linear or branched C1-C30 alkyl or C3-C30 alkenyl radical which may carry one or more hydroxyl substituents and which may contain, in the carbon chain, one or more selected heteroatoms; among the atoms of oxygen, nitrogen and silicon. Although in formula (XIII) above, only the isomers in which the cyano substituent is in the cis-position relative to the para-amino-phenyl substituent are represented, this formula should be understood to include also the corresponding trans-isomers; for each of the two double bonds and independently, the cyano and para-amino-phenyl substituents may be in the cis or trans configuration with respect to each other.

By way of example, mention may be made of 2-ethylhexyl 2-cyano-344- (acetylamino) phenyl] -acrylate dimer of formula: J / polyvalent metals Another particular family of insoluble organic filters in accordance with the invention are polyvalent metal salts (for example Ca 2+, Zn 2+, Mg 2+, Ba 2+, Al 3 + or Zr 4 +) of organic sulphonic or carboxylic filters such as polyvalent metal salts of sulphonated derivatives of benzylidene camphor such as those described in application FR-A 2 639,347; polyvalent metal salts of sulfonated benzimidazole derivatives such as those described in application EP-A-893119; the polyvalent metal salts of cinnamic acid derivatives such as those described in patent application JP-87 166 517. And mention may also be made of metal or ammonium or substituted ammonium complexes of organic UV-A and or UV-B as described in patent applications WO93 / 10753, WO93 / 11095 and WO95 / 05150.

Among the insoluble organic UV filters, mention may also be made of the compound 1,1 '- (1,4-piperazinediyl) bis [14244- (diethylamino) -2-hydroxybenzoyl] phenyl] methanone (CAS 919803-06-8). following structure: / N as described in WO2007 / 071584; this compound being advantageously used in micronized form (average size of 0.02 to 2 μm) obtainable, for example, according to the micronization process described in applications GB-A-2 303 549 and EP-A-893119 and in particular in the form of aqueous dispersion. According to a particularly preferred form of the invention, the insoluble organic UV screening agents chosen from (i) the symmetrical triazine filters substituted with naphthalenyl groups or polyphenyl groups described in US Pat. No. 6,225,467, the application WO2004 / 085412 (see Compounds 6 and 9) or the document "Symetrical Triazine Derivatives" IP.COM IPCOM000031257 Journal, Inc. WEST HENRIETTA, NY, US (September 20, 2004) including 2,4,6-tris (di-phenyl) -triazine and 2 , 4,6-tris (ter-phenyl) -triazine, which is incorporated in patent applications W006 / 035000, W006 / 034982, W006 / 034991, W006 / 035007, WO2006 / 034992, WO2006 / 034985, these compounds being advantageously used in micronized form (average particle size of 0.02 to 3 μm) obtainable, for example, according to the micronization process described in applications GB-A-2 303 549 and EP-A-893119 and in particular in the form of an aqueous dispersion ; (ii) the methylene bis- (hydroxyphenylbenzotriazole) compounds of formula (IV) below: (IV) T in which the radicals T10 and T11, which may be identical or different, denote a C 1 -C 18 alkyl radical which may be substituted with one or a plurality of radicals selected from C1-C4alkyl, C5-C12cycloalkyl or aryl radical; (iii) and mixtures thereof.

According to a particularly preferred embodiment of the invention, the methylene bis (hydroxyphenyl benzotriazole) compounds of formula (IV) are in the form of an aqueous dispersion of particles having an average particle size which varies from 0.01 to 5 μm and more preferably from 0, 0.1 to 2 μm and more particularly 0.020 to 2 μm with at least one surfactant of structure CnH2n-OO (C61-11005) xH in which n is an integer of 8 to 16 and x is the average degree of polymerization of the unit (C6H1005) and varies from 1.4 to 1.6 as defined above. Said surfactant is preferably used at a concentration of from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the benzotriazole filter and the amount of benzotriazole filter of formula (I) in the aqueous dispersion varies from preferably from 10 to 50% by weight and more preferably from 30 to 50% by weight relative to the total weight of the dispersion. The average particle diameter was measured by a Cutter N4 PLUS® particle size distribution analyzer manufactured by Bechman Coulter INC. According to a particularly preferred form of the invention, the methylene bis (hydroxyphenyl benzotriazole) compounds of formula (IV) may be in the form of an aqueous dispersion of particles having an average particle size ranging from 0.02 to 2 μm and more preferably from 0.01 to 1.5 μm and more particularly from 0.02 to 1 μm in the presence of at least one mono- (C 8 -C 20) alkyl polyglycerol ester having a glycerol polymerization degree of at least 5 such as the aqueous dispersions described in application WO2009 / 063392.

As examples of polyglyceryl mono- (C 8 -C 20) alkyl polyglycol surfactants, mention may be made of decaglyceryl caprate, decaglyceryl laurate, decaglyceryl myristate, decaglyceryl oleate, decaglyceryl stearate and decaglyceryl isostearate. hexaglyceryl caprate, hexaglyceryl laurate, hexaglyceryl myristate, hexaglyceryl oleate, hexaglyceryl stearate, hexaglyceryl isostearate, pentaglyceryl caprate, pentaglyceryl laurate, myristate pentaglyceryl, pentaglycerol oleate, pentaglyceryl stearate, pentaglyceryl isostearate. 01-1 CH2 In particular, decaglyceryl caprate such as the products sold under the following trade names SUNSOFT Q10Y®, SUNSOFT Q10S®, SUNSOFT Q12Y®, SUNSOFT Q12S®, SUNSOFT M12J® by the company Taiyo Kagaku Co. will be used more particularly. Ltd., NIKKOL Decaglyn 1-L by Nikko Chemicals Co. Ltd., RYOTO-Polyglycerylester L-10D® and L-7D® by MitsubishiKagaku Co. Ltd., - decaglyceryl laurate such as products sold under the following trade names SUNSOFT Q14Y®, SUNSOFT Q14S®, SUNSOFT Q12Y®, SUNSOFT Q12S®, SUNSOFT M12J® by Taiyo Kagaku Co. Ltd., NIKKOL Decaglyn 1-M® by Nikko Chemicals Co. Ltd., RYOTO- Polyglyceryl ester M-10D and M-7D by Mitsubishi-Kagaku Co. Ltd., - Decaglyceryl stearate, such as the products sold under the following trade names SUNSOFT Q18Y®, SUNSOFT Q18S®, SUNSOFT Q12Y®, SUNSOFT Q12S®, SUNSOFT M12J® by Taiyo Kagaku Co. Ltd., NIKKOL Decaglyn 1-SV by Nikko Chemicals Co. Ltd., RYOTO-Polyglycerylester S-15D® by Mitsubishi-Kagaku Co. Ltd., - hexaglieryl caprate such as the products sold under the following trade names NIKKOL Hexaglyn 1- L® by Nikko Chemicals Co. Ltd., GLYSURF 6ML by Aoki Oil Industrial Co. Ltd., UNIGLY GL-106® by Nippon Oil & Fats Co. Ltd., - hexaglyceryl myristate such as products sold under the trade names NIKKOL Hexaglyn 1-M®, NIKKOL Hexaglyn 1-0V® by Nikko Chemicals Co. Ltd., GLYSURF 6ML® by Aoki Oil Industrial Co. Ltd., UNIGLY GL-106 by the company Nippon Oil & Fats Co. Ltd., - hexaglyceryl stearate, such as the products sold under the following trade names NIKKOL Hexaglyn 1-M®, NIKKOL Hexaglyn 1-SV® by Nikko Chemicals Co. Ltd., EMALEXMSG-6K ® by Nihon-Emulsion Co. Ltd., UNIGLY GL-106 by Nippon Oil & Fats Co. Ltd. hexaglyceryl isostearate such as the products sold under the trade names MATSUMATE MI-610® by the company Matsumoto Fine Chemical Co. Ltd., pentaglyceryl caprate such as the products sold under the following trade names SUNSOFT A10E ®, by Taiyo Kagaku Co.

Ltd., - pentaglyceryl laurate such as the products sold under the following trade names SUNSOFT Al2E®, SUNSOFT A121E®, by the company Taiyo Kagaku Co. Ltd., - pentaglyceryl myristate such as the products sold under the trade names SUNSOFT A14E®, SUNSOFT A141E®, by Taiyo Kagaku Co. Ltd., - pentaglyceryl oleate, such as the products sold under the following trade names SUNSOFT A17E®, SUNSOFT A171E®, by Taiyo Kagaku Co. Ltd., - pentaglyceryl stearate such as the products sold under the following trade names SUNSOFT A18E®, SUNSOFT A181E®, by the company Taiyo Kagaku Co. Ltd., Among these surfactants, it is preferred to use those having a higher or equal HLB at 14.5 and more preferably greater than or equal to 15. Examples of polyglycerol mono- (C 8 -C 20) alkyl polyglycol surfactants having a degree of polymerization having a glycerol polymerization degree of at least 5 with an HLB of greater than or equal to 14.5, mention may be made of decaglyceryl caprate, decaglyceryl laurate, decaglyceryl myristate, decaglyceryl oleate, decaglyceryl stearate, decaglyceryl isostearate, laurate. hexaglyceryl, pentaglyceryl caprate, pentaglyceryl laurate, pentaglyceryl myristate, pentaglyceryl oleate, pentaglyceryl stearate. As examples of polyglycerol mono- (C 8 -C 20) alkyl esters having a degree of polymerization having a glycerol polymerization degree of at least 5 having an HLB greater than or equal to 15, mention may be made of decaglyceryl caprate, laurate decaglyceryl.

The amount of methylene bis (hydroxyphenyl benzotriazole) compound of formula (IV) in the aqueous dispersion preferably ranges from 10 to 50% by weight and more preferably from 30 to 50% by weight relative to the total weight of the dispersion.

Preferably, the weight ratio of methylene bis (hydroxyphenyl benzotriazole) / mono- (C 8 -C 20) alkyl polyglycerol compound varies from 0.05 to 0.5 and more preferably from 0.1 to 0.3. The compound 2,2'-methylene-bis- [6- (2H-benzotriazol-2-yl) -4 is preferably used in these aqueous dispersions, such as methylene bis (hydroxyphenylbenzotriazole) compound of formula (IV). - (1,1,3,3-tetramethylbutyl) phenol] of structure: compound (a) such as the commercial product sold under the name TINOSORB M® by BASF which is an aqueous dispersion comprising decylglucoside, xanthan gum and propylene glycol (INCI name: Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (and) Aqua (and) Decyl Glucoside (and) Propylene Glycol (and) Xanthan Gum).

The insoluble organic UV screening agent (s) of the invention are present at a concentration of active material preferably ranging from 0.1 to 15% by weight, and more particularly from 0.5 to 10% by weight relative to the total weight. of the composition.

OIL PHASE The compositions in accordance with the invention comprise at least one oily phase.

For the purposes of the invention, the term "oily phase" is intended to mean a phase comprising at least one oil and all the liposoluble and lipophilic ingredients and fatty substances used for the formulation of the compositions of the invention. The term "oil" means any fatty substance in liquid form at ambient temperature (20-25 ° C.) and at atmospheric pressure (760 mmHg). An oil suitable for the invention may be volatile or non-volatile. An oil suitable for the invention may be selected from hydrocarbon oils, silicone oils, fluorinated oils and mixtures thereof. A hydrocarbon oil suitable for the invention may be an animal hydrocarbon oil, a vegetable hydrocarbon oil, a mineral hydrocarbon oil, or a synthetic hydrocarbon oil. An oil suitable for the invention may advantageously be chosen from mineral hydrocarbon oils, vegetable hydrocarbon oils, synthetic hydrocarbon oils, silicone oils, and mixtures thereof.

For the purposes of the present invention, the term "silicone oil" means an oil comprising at least one silicon atom, and in particular at least one Si-O group. The term "hydrocarbon oil" means an oil containing mainly hydrogen and carbon atoms. The term "fluorinated oil" means an oil comprising at least one fluorine atom.

A hydrocarbon oil which is suitable for the invention may, in addition, optionally comprise oxygen, nitrogen, sulfur and / or phosphorus atoms, for example, in the form of hydroxyl, amine, amide, ester or ether groups. and in particular in the form of hydroxyl, ester, ether or acid groups.

The oily phase generally comprises, in addition to the at least one lipophilic UV filter, at least one volatile or non-volatile hydrocarbon oil and / or a volatile and / or non-volatile silicone oil. For the purposes of the invention, the term "volatile oil" means an oil capable of evaporating on contact with the skin or the keratin fiber in less than one hour, at ambient temperature and atmospheric pressure. The volatile oil (s) of the invention are volatile cosmetic oils which are liquid at ambient temperature and have a non-zero vapor pressure at ambient temperature and atmospheric pressure, in particular ranging from 0.13 Pa to 40,000 Pa (10- 3 to 300 mmHg), in particular ranging from 1.3 Pa to 13 000 Pa (0.01 to 100 mmHg), and more particularly ranging from 1.3 Pa to 1300 Pa (0.01 to 10 mm). of Hg). By "non-volatile oil" is meant an oil remaining on the skin or the keratin fiber at ambient temperature and atmospheric pressure for at least several hours and having in particular a vapor pressure of less than 10 -3 mmHg (0.13 Pa). . Hydrocarbon oils As non-volatile hydrocarbon oils that can be used according to the invention, mention may be made in particular of: (i) hydrocarbon-based oils of vegetable origin, such as triesters of glycerides, which are generally triesters of fatty acids and of glycerol, the acids of which are fatty acids may have various chain lengths of C4 to C24, the latter may be linear or branched, saturated or unsaturated; these oils include wheat germ, sunflower, grape seed, sesame, maize, apricot, castor, shea, avocado, olive, soya, sweet almond, palm, rapeseed, cotton, hazelnut, macadamia, jojoba, alfalfa, poppy, pumpkin, sesame, pumpkin, rapeseed, blackcurrant, evening primrose, millet, barley, quinoa, rye, safflower, bancoulier, passiflora, muscat rose; or alternatively caprylic / capric acid triglycerides, such as those sold by the company Stéarineries Dubois or those sold under the names Miglyol 810®, 812® and 818® by the company Dynamit Nobel, (ii) synthetic ethers having from 10 to 40 carbon atoms; (iii) linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as parleam, squalane, and mixtures thereof; (iv) synthetic esters such as oils of formula RCOOR 'in which R represents the residue of a linear or branched fatty acid containing from 1 to 40 carbon atoms and R' represents a hydrocarbon chain, in particular branched, containing from 1 to 40 carbon atoms with the proviso that R + R 'is 10, such as, for example, purcellin oil (cetostearyl octanoate), isopropyl myristate, isopropyl palmitate, C12-C15 alcohols benzoate, and the like. product sold under the trade name "Finsolv TN®" or "Witconol TN®" by the company WITCO or "TEGOSOFT TN ®" by the company EVONIK GOLDSCHMIDT, 2-ethylphenyl benzoate as the commercial product sold under the name "X- TEND 226® by the company ISP, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate sold under the name "Dub Dis" by Stearinerie Dubois, octanoates, decanoates or ricinoleates of alcohols or polyalcohols such as propylene glycol dioctanoate; hydroxyl esters such as isostearyl lactate, diisostearyl malate; and pentaerythritol esters; citrates or tartrates such as linear C12-C13 di-alkyl tartrates such as those sold under the name COSMACOL ETI® by the company ENICHEM AUGUSTA INDUSTRIALE as well as linear C14-C15 di-alkyl tartrates such as those sold under the name COSMACOL ETL® by the same company; acetates. (y) branched-chain and / or unsaturated carbon-chain liquid fatty alcohols having from 12 to 26 carbon atoms, such as octyl dodecanol, isostearyl alcohol, oleic alcohol, 2-hexyldecanol, 2- butyloctanol, 2-undecylpentadecanol; (vi) higher fatty acids such as oleic acid, linoleic acid, linolenic acid; (vii) carbonates, such as dicaprylyl carbonate, such as the product sold under the name "Cetiol CC®" by Cognis; (viii) fatty amides, such as Isopropyl N-lauroyl sarcosinate, such as the product sold under the trade name Eldew SL 205® from Ajinomoto, and mixtures thereof, Among the nonvolatile hydrocarbon oils that can be used according to the invention, it will be more particularly preferred glyceride triesters and in particular caprylic / capric acid triglycerides, synthetic esters and in particular isononyl isononanoate, oleyl erucate, C12-C15 alcohols benzoate, 2-ethylphenyl benzoate and fatty alcohols, in particular octyldodecanol, As volatile hydrocarbon oils that may be used according to the invention, mention may be made in particular of hydrocarbon-based oils having from 8 to 16 carbon atoms, and in particular C8-C16 branched alkanes such as C8-C16 isoalkanes. C16 of petroleum origin (also called isoparaffins) such as isododecane (also called 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, the oils sold under the names co Examples are Isopar or permetyl derivatives, branched C8-C16 esters, isohexyl neopentanoate, and mixtures thereof.

Mention may also be made of the alkanes described in the patent applications of Cognis WO 2007/068371, or WO2008 / 155059 (mixtures of distinct alkanes and differing from at least one carbon). These alkanes are obtained from fatty alcohols, themselves obtained from coconut oil or palm oil. mention may be made of the mixtures of n-undecane (C11) and n-tridecane (C13) obtained in Examples 1 and 2 of Application WO2008 / 155059 from Cognis. Mention may also be made of n-dodecane (C12) and n-tetradecane (C14) sold by Sasol respectively under the references PARAFOL 12-97® and PARAFOL 14-9®7, and mixtures thereof.

Other volatile hydrocarbon oils such as petroleum distillates, in particular those sold under the name Shell Solt® by Shell, can also be used. According to one embodiment, the volatile solvent is chosen from volatile hydrocarbon oils having 8 to 16 carbon atoms and mixtures thereof. b) Silicone oils The non-volatile silicone oils may be chosen in particular from non-volatile polydimethylsiloxanes (PDMS), polydimethylsiloxanes containing alkyl or alkoxy groups, during and / or at the end of the silicone chain, groups each having from 2 to 24 carbon atoms. carbon, phenyl silicones such as phenyl trimethicones, phenyl dimethicones, phenyl trimethylsiloxy diphenylsiloxanes, diphenyl dimethicones, diphenyl methyldiphenyl trisiloxanes, 2-phenylethyl trimethylsiloxysilicates; As volatile silicone oils, mention may be made, for example, of volatile linear or cyclic silicone oils, in particular those having a viscosity of 8 centistokes (8 × 10 -6 m 2 / s), and having in particular from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having from 1 to 10 carbon atoms. As volatile silicone oil that may be used in the invention, mention may be made in particular of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyltrisiloxane, heptamethyloctyltrisiloxane, hexamethyl disiloxane, octamethyltrisiloxane, decamethyl tetrasiloxane, dodecamethyl pentasiloxane and mixtures thereof. It is also possible to mention volatile alkyltrisiloxane linear oils of general formula (I): ## STR1 ## where R represents an alkyl group comprising from 2 to 4 carbon atoms and one of which several hydrogen atoms may be substituted with a fluorine or chlorine atom. Among the oils of general formula (I), mention may be made of: 3-butyl 1,1,1,3,5,5,5-heptamethyltrisiloxane, 3-propyl 1,1,1,3,5,5 , 5-heptamethyltrisiloxane, and 3-ethyl-1,1,1,3,5,5,5-heptamethyltrisiloxane, corresponding to the oils of formula (I) for which R is respectively a butyl group, a propyl group or an ethyl group. Fluorinated oils Fluorinated volatile oils such as nonafluoromethoxybutane, nonafluoromethoxybutane, decafluoropentane, tetradecafluorohexane, dodecafluoropentane and mixtures thereof can also be used.

An oily phase according to the invention may further comprise, mixed with or solubilized in oil, other fatty substances. Another fatty substance that may be present in the oily phase may be, for example: a fatty acid chosen from fatty acids containing from 8 to 30 carbon atoms, such as stearic acid, lauric acid or palmitic acid; and oleic acid; a wax chosen from waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, lignite waxes or microcrystalline waxes, ceresin or ozokerite, synthetic waxes such as waxes polyethylene, Fischer-Tropsch waxes; a gum chosen from silicone gums (dimethiconol), a pasty compound, such as polymeric or non-polymeric silicone compounds, esters of an oligomeric glycerol, arachidyl propionate, triglycerides of fatty acids and their derivatives, - and their mixtures. Preferably, the overall oily phase, including all the lipophilic substances in the composition capable of being solubilized in this same phase, represents from 5 to 95% by weight, and preferably from 10 to 80% by weight relative to the weight. total of the composition. AQUEOUS PHASE The compositions according to the invention may further comprise at least one aqueous phase. The aqueous phase contains water, and optionally other organic solvents that are soluble or miscible with water. An aqueous phase that is suitable for the invention may comprise, for example, a water chosen from natural spring water, such as La Roche-Posay water, Vittel water, or Vichy waters, or water. floral.

Solvents that are soluble or miscible in water that are suitable for the invention include short-chain monohydric alcohols, for example C1-C4, such as ethanol or isopropanol; diols or polyols such as ethylene glycol, 1,2-propylene glycol, 1,3-butylene glycol, hexylene glycol, diethylene glycol, dipropylene glycol, 2-ethoxyethanol, diethylene glycol monomethyl ether, triethylene glycol monomethyl ether, glycerol, and sorbitol, and mixtures thereof. According to a preferred embodiment, ethanol, propylene glycol, glycerine, and mixtures thereof may be used more particularly.

According to one particular form of the invention, the overall aqueous phase, including all the hydrophilic substances of the composition capable of being solubilized in this same phase, represents from 5 to 95% by weight, and preferably from 10 to 80% by weight. weight relative to the total weight of the composition. ADDITIVES a) Additional UV Filters: The compositions according to the invention may additionally contain one or more additional UV screening agents chosen from hydrophilic or lipophilic organic UV filters and / or one or more inorganic pigments. Preferably, it will consist of at least one hydrophilic organic UV filter, lipophilic or insoluble.

By "hydrophilic UV filter" is meant any organic or inorganic cosmetic or dermatological compound filtering the UV radiation capable of being completely dissolved in the molecular state in a liquid aqueous phase or of being solubilized in colloidal form (for example in the form of micellar) in a liquid aqueous phase. By "lipophilic filter" is meant any organic or inorganic cosmetic or dermatological compound filtering UV radiation capable of being completely dissolved in the molecular state in a liquid fatty phase or to be solubilized in colloidal form (for example in micellar form ) in a liquid fatty phase. The complementary organic UV screening agents are chosen in particular from cinnamic compounds; anthranilate compounds; salicylic compounds, dibenzoylmethane compounds, benzylidene camphor compounds; benzophenone compounds; the compounds 3, p-diphenylacrylate; triazine compounds; benzotriazole compounds; benzalmalonate compounds including those cited in US5624663; benzimidazole derivatives; imidazoline compounds; bis-benzoazolyl compounds as described in patents EP669323 and US 2,463,264; p-aminobenzoic compounds (PABA); benzoxazole compounds as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; filter polymers and silicone filters such as those described in particular in the application WO-93/04665; dimers derived from α-alkylstyrene such as those described in patent application DE19855649; 4,4-diarylbutadiene compounds as described in Applications EP0967200, DE19746654, DE19755649, EP-A-1008586, EP1133980 and EP133981 and mixtures thereof. Examples of organic photoprotective agents are those referred to below under their names. INCI: Cinnamic compounds: Ethylhexyl Methoxycinnamate sold in particular under the trade name PARSOL MCX® by DSM Nutritial Products Isopropyl Methoxycinnamate Isoamyl p-Methoxycinnamate sold under the trade name NEO HELIOPAN E 1000® by Symrise DEA Methoxycinnamate, Diisopropyl Methylcinnamate, Glyceryl Ethylhexanoate Dimethoxycinnamate. Para-Aminobenzoic Compounds: PABA, Ethyl PABA, Ethyl Dihydroxypropyl PABA, Ethylhexyl Dimethyl PABA sold in particular under the name "ESCALOL 507®" by ISP, Glyceryl PABA, PEG-25 PABA sold under the name "Uvinul P 25®" by BASF. Salicylic compounds: Homosalate sold under the name "Eusolex HMS®" by Rona / EM Industries, Ethylhexyl Salicylate sold under the name "Neo Heliopan OS®" by Symrise, Dipropylene Glycol Salicylate sold under the name "DIPSAL®" by SCHER, TEA Salicylate, sold under the name "NEO HELIOPAN TS®" by Symrise. Compounds 6,13-diphenylacrylate: Octocrylene sold in particular under the trade name "UVINUL N 539®" by BAS F, Etocrylene, sold in particular under the trade name "UVINUL N 35®" by BASF.

Benzophenone compounds: Benzophenone-1 sold under the trade name Uvinul 400® by BASF, Benzophenone-2 sold under the trade name Uvinul D 50® by BASF Benzophenone-3 or Oxybenzone, sold under the trade name Uvinul M 40 ® by BASF, Benzophenone-4 sold under the trade name "UVINUL MS 40®" by BASF, Benzophenone-5 Benzophenone-6 sold under the trade name "Helisorb 11®" by Norquay Benzophenone-8 sold under the trade name "Spectra -Sorb UV-24® "by American Cyanam id Benzophenone-9 sold under the trade name" UVINUL DS 49® "by BASF, Benzophenone-12 2- (4-diethylamino-2-hydroxybenzoyl) -benzoate n-hexyl sold under the trade name "UVINUL A Plus ®" or in combination with octylmethoxycinnamate under the trade name "UVINUL A Plus B®" by BASF. Benzylidene camphor compounds: 3-Benzylidene camphor manufactured under the name "MEXORYL SD®" by CHIMEX, 4-Methylbenzylidene camphor sold under the name "EUSOLEX 6300®" by 10 MERCK, Benzylidene Camphor Sulfonic Acid manufactured under the name "MEXORYL SL®" by CHIMEX, Camphor Benzalkonium Methosulfate manufactured under the name "MEXORYL SO®" by CHIMEX, Terephthalylidene Dicamphor Sulfonic Acid manufactured under the name "MEXORYL SX®" by CHIMEX, Polyacrylamidomethyl Benzylidene Camphor manufactured under the name "MEXORYL SW®" by CHIMEX. Phenylbenzimidazole compounds: Phenylbenzimidazole Sulfonic Acid sold in particular under the trade name "Eusolex 232®" by Merck. Bis-benzoazolyl compounds Disodium Phenyl Dibenzimidazole Tetrasulfonate sold under the trade name "NEO HELIOPAN AP®" by Haarmann and REIMER. Phenyl benzotriazole compounds: Drometrizole Trisiloxane sold under the name "Silatrizole®" by Rhodia Chimie. Triazine Compounds: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine sold under the trade name Tinosorb S® by BASF, Ethylhexyl Triazone sold in particular under the trade name Uvinul T 35 150® by BASF, Diethylhexyl Butamido Triazone sold under the name commercial "UVASORB HEB ®" by SIGMA 3V, - 2,4,6-tris (dineopentyl 4'-amino benzalmalonate) -s-triazine, - 2,4,6-tris (diisobutyl 4'-amino benzalmalonate) triazine, 40 - 2,4-bis (n-butyl 4'-aminobenzoate) -6- (aminopropyltrisiloxane) -s-triazine, dineopentyl 2,4-bis (4'-aminobenzalmalonate) (N-Butyl 4'-aminobenzoate) -s-triazine, triazine silicones substituted with two aminobenzoate groups as described in patent EP0841341, in particular 2,4-bis (n-butyl 4'-aminobenzalmalonate) -6 - [(3- {1,3,3,3-tetramethyl-1-trimethylsilyloxe disiloxanyllpropyl) aminyl] -s-triazine. Anthranilic compounds: Menthyl anthranilate sold under the trade name "NEO HELIOPAN MA®" by Symrise. Imidazoline compounds: Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate. Benzalmalonate compounds: Polyorganosiloxane containing benzalmalonate functions, such as Polysilicone-15 sold under the trade name "Parsol SLX (D" by Hoffmann La Roche) Compounds 4,4-diarylbutadiene: -1,1-dicarboxy (2,2'-dimethylpropyl) 4,4-diphenylbutadiene Benzoxazole compounds: 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino- 1,3,5-triazine sold under the name Uvasorb K2A® by Sigma 3V The preferred organic screening agents are chosen from ethylhexyl methoxycinnamate, ethylhexyl salicylate, homosalate, octocrylene, phenylbenzimidazole sulphonic acid, benzophenone-3 and benzophenone-4. N-hexyl benzophenone-5,2- (4-diethylamino-2-hydroxybenzoyl) benzoate 4-Methylbenzylidene camphor, Terephthalylidene Dicamphor Sulfonic Acid, Disodium Phenyl Dibenzimidazole Tetrasulfonate, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Ethylhexyl Triazone, Diethylhexyl Butamido Triazone, 2,4,6-tris- (4'-amino benzalmalonate) 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) -s-triazine 2,4-bis- (4-n-butyl 4-aminobenzoate) -6- (aminopropyltrisiloxane) -s-triazine, 2,4-bis (dineopentyl 4'-aminobenzalmalonate) -6- (n-butyl 4'-aminobenzoate) -s-triazine, 2,4-bis (n-butyl) -4'-aminobenzalmalonate ) -6 - [(3- {1,3,3,3-tetramethyl-1-trimethylsilyloxy] disiloxanyllpropyl) aminod-triazine Drometrizole Trisiloxane Polysilicone-1,1-dicarboxy (2,2'- dimethyl-propyl) -4,4-diphenylbutadiene 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) imino-1, 3,5-triazine and mixtures thereof. Particularly preferred organic screening agents are selected from ethylhexyl salicylate, homosalate, octocrylene, n-hexyl 2- (4-diethylamino-2-hydroxybenzoyl) benzoate. Terephthalylidene Dicamphor Sulfonic Acid, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Ethylhexyl Triazone, Diethylhexyl Butamido Triazone, 2,4-bis- (n-butyl 4'-aminobenzalmalonate) -6 - [(3- {1,3,3,3-tetramethyl) -2- 1-trimethylsilyloxy] disiloxanyllpropyl) amino] s-triazine, Drometrizole Trisiloxane and mixtures thereof. The inorganic UV filters used in accordance with the present invention are metal oxide pigments. More preferably, the inorganic UV filters 25 of the invention are metal oxide particles having an average element particle size of less than or equal to 0.5 μm, more preferably between 0.005 and 0.5 μm and even more preferentially between 0.01 and 0.2 μm, more preferably between 0.01 and 0.1 μm, and more preferably between 0.015 and 0.05 μm. They may be chosen in particular from oxides of titanium, zinc, iron, zirconium, cerium or their mixtures. Such metal oxide pigments, coated or uncoated, are in particular described in patent application EP-A-0 518 773. As commercial pigments mention may be made of the products sold by the companies SACHTLEBEN PIGMENTS, TAYCA, MERCK AND Degussa. The metal oxide pigments may be coated or uncoated. Coated pigments are pigments which have undergone one or more surface treatments of a chemical, electronic, mechanochemical and / or mechanical nature with compounds such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids, metal alkoxides (of titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin ), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.

The coated pigments are more particularly titanium oxides coated with: - silica such as the product "Sunveil" from the company IKEDA, - silica and iron oxide such as the product "SUNVEIL F" from the company IKEDA, - silica and alumina, such as the products "MICROTITANIUM DIOXIDE 10 MT 500 SA" and "MICROTITANIUM DIOXIDE MT 100 SA" from the company TAYCA, "TIOVEIL" from the company TIOXIDE, - alumina such as the products "TIPAQUE TTO -55 (B) "and" TIPAQUE TTO-55 (A) "from the company ISHIHARA, and" UVT 14/4 "from the company SACHTLEBEN PIGMENTS, 15 - alumina and aluminum stearate such as the products" MICROTITANIUM DIOXIDE MT 100 T, MT 100 TX, MT 100 Z, MT-01 "from the company TAYCA, the products" Solaveil CT-10 W "and" Solaveil CT 100 "from the company UNIQEMA and the product" Eusolex T-AVO from the company MERCK, silica, alumina and alginic acid such as the product "MT-100 AQ" from the company TAYCA, alumina and aluminum laurate such as product "MICROTITANIUM DIOXIDE MT 100 S" from TAYCA, - iron oxide and iron stearate such as the product "MICROTITANIUM DIOXIDE MT 100 F" from TAYCA, 25 - zinc oxide and stearate zinc such as the product "BR 351" from TAYCA, - silica and alumina and treated with a silicone such as the products "MICROTITANIUM DIOXIDE MT 600 SAS", "MICROTITANIUM DIOXIDE MT 500 SAS" or "MICROTITANIUM DIOXIDE" MT 100 SAS "from the company TAYCA, 30-silica, alumina, aluminum stearate and treated with a silicone such as the product" STT-30-DS "from TITAN KOGYO, - silica and treated by a silicone such as the product "UV-TITAN X 195" from the company SACHTLEBEN PIGMENTS, - alumina and treated with a silicone such as the products "TIPAQUE TTO-55 35 (S)" from the company ISHIHARA, or " UV TITAN M 262 "from the company SACHTLEBEN PIGMENTS, - triethanolamine such as the product" STT-65-S "from the company TITAN KOGYO, - acid stearic acid such as the product "TIPAQUE TTO-55 (C)" from the company ISHIHARA, 40 sodium hexametaphosphate such as the product "MICROTITANIUM DIOXIDE MT 150 W 'from the company TAYCA. the TiO 2 treated with octyl trimethyl silane sold under the trade name "T 805" by the company Degussa Silices, the TiO 2 treated with a polydimethylsiloxane sold under the trade name "70250 Cardre UF TiO2S13" by CARDRE; TiO2 anatase / rutile treated with a polydimethylhydrogensiloxane sold under the trade name "MICRO TITANIUM DIOXIDE USP GRADE 5 HYDROPHOBIC" by the company COLOR TECHNIQUES. It is also possible to mention TiO 2 pigments doped with at least one transition metal such as iron, zinc, manganese and more particularly manganese. Preferably, said doped pigments are in the form of an oily dispersion. The oil present in the oily dispersion is preferably chosen from triglycerides including those of capric / caprylic acids. The oily dispersion of titanium oxide particles may further comprise one or more dispersing agents such as, for example, a sorbitan ester such as sorbitan isostearate, a fatty acid ester of polyoxyalkylenated glycerol such as TRI-PPG3 MYRISTYLETHER CITRATE and POLYGLYCERYL-3 POLYRICINOLEATE. Preferably, the oily dispersion of titanium oxide particles comprises at least one dispersing agent chosen from fatty acid esters and polyoxyalkylenated glycerol. More particularly, mention may be made of the oily dispersion of manganese-doped TiO 2 particles in capric / caprylic acid triglyceride in the presence of TRI-PPG-3 MYRISTYLETHER CITRATE and POLYGLYCERYL-3-POLYRICINOLEATE and SORBITAN ISOSTERATE INCI name: TITANIUM DIOXIDE (and) TRI-PPG-3 MYRISTYLETHER CITRATE (and) POLYGLYCERYL-3 RICINOLEATE (and) SORBITAN ISOSTEARATE as the product sold under the trade name OPTISOL TD50 by the company CRODA. Uncoated titanium oxide pigments are for example sold by the company Tayca under the trade names "MICROTITANIUM DIOXIDE MT 500 B" or "MICROTITANIUM DIOXIDE MT600 30 B", by the company DEGUSSA under the name "P 25", by the company WACKHER under the name "transparent titanium oxide PW ', by the company MIYOSHI KASEI under the name" UFTR ", by the company TOMEN under the name" ITS "and by the company TIOXIDE under the name" TIOVEIL AQ ". The uncoated zinc oxide pigments are, for example: those marketed under the name Z-cote by the company Sunsmart, those marketed under the name Nanox by the company Elementis, and those marketed under the name Z-cote; "Nanogard WCD 2025" by the company Nanophase Technologies The coated zinc oxide pigments are, for example: those marketed under the trademark "Zinc Oxide CS-5" by Toshibi (ZnO) coated with polymethylhydrogenosiloxane); those marketed under the name "Nanogard Zinc Oxide FN" by Nanophase Technologies (as a 40% dispersion in Finsolv TN, C12-C15 alcohol benzoate); those marketed under the name "DAITOPERSION Zn-30" and "DAITOPERSION Zn-50" by the company Daito (dispersions in cyclopolymethylsiloxane / polydimethylsiloxane oxyethylenated, containing 30% or 50% of zinc oxides coated with silica and polymethylhydrogensiloxane) ; those marketed under the name "NFD Ultrafine ZnO" by the company Daikin (ZnO coated with perfluoroalkyl phosphate and a copolymer based on perfluoroalkylethyl dispersed in cyclopentasiloxane); those marketed under the name "SPD-Z1" by Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane); those marketed under the name "Escalol Z100" by the company ISP (ZnO treated alumina and dispersed in the mixture methoxycinnamate ethylhexyl / PVP-hexadecene copolymer / methicone); those marketed under the name "Fuji ZnO-SMS-10" by the company Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane); those marketed under the name "Nanox Gel TN" by Elementis (ZnO dispersed at 55% in C12-C15 alcohols benzoate with hydroxystearic acid polycondensate). The uncoated cerium oxide pigments may for example be those sold under the name "COLLOIDAL CERIUM OXIDE" by the company RHONE POULENC. Uncoated iron oxide pigments are for example sold by ARNAUD under the names "NANOGARD WCD 2002 (FE 45B)", "NANOGARD IRON FE 45 BL AQ", "NANOGARD FE 45R AQ," NANOGARD WCD 2006 (FE 45R) ", or by the company MITSUBISHI under the name" TY220 "The coated iron oxide pigments are for example sold by ARNAUD under the names" NANOGARD WCD 2008 (FE 45B FN) "," NANOGARD WCD 2009 (FE 45B 556) "," NANOGARD FE 45 BL 345 "," NANOGARD FE 45 BL ", or by BASF under the name" TRANSPARENT IRON OXIDE. "40 One can also mention mixtures of oxides metals, in particular titanium dioxide and cerium dioxide, including the titanium dioxide and silica-coated cerium dioxide equivalent compound sold by the company IKEDA under the name "SUNVEIL A", as well as the mixture of carbon dioxide and titanium dioxide. titanium and zinc dioxide coated with alumina, silica and silicone such as the product "M 261" sold by SACHTLEBEN PIGMENTS or coated with alumina, silica and glycerine such as the product "M 211" sold by SACHTLEBEN PIGMENTS.

According to the invention, titanium oxide pigments, coated or uncoated, are particularly preferred. The complementary UV filters according to the invention are preferably present in the compositions according to the invention at a content ranging from 0.1% to 45% by weight and in particular from 5% to 30%, by weight, relative to the total weight. of the composition. b) Other Additives: The compositions in accordance with the present invention may furthermore comprise conventional cosmetic adjuvants, chosen in particular from organic solvents, ionic or nonionic thickeners, softeners, humectants, opacifiers, stabilizers, emollients, silicones, anti-foam agents, perfumes, preservatives, anionic, cationic, nonionic, zwitterionic or amphoteric surfactants, actives, fillers, polymers, propellants, alkalinizing or acidifying agents or any other ingredient usually used in the cosmetic and / or dermatological field. Among the organic solvents, mention may be made of alcohols other than the C 1 -C 4 mono-alkanols as defined above and in particular C 2 -C 8 short chain polyols, such as glycerine, diols such as caprylyl glycol, pentanediol, and the like. 1,2, propanediol, butanediol, glycols and glycol ethers such as ethylene glycol, propylene glycol, butylene glycol, dipropylene glycol or diethylene glycol. As thickeners, mention may be made of carboxyvinyl polymers such as Carbopols® (Carbomers) and Pemulen such as Pemulen TR1® and Pemulen TR2® (acrylate / C10-C30-alkylacrylate copolymer); polyacrylamides, for example crosslinked copolymers sold under the names Sepigel 305® (CTFA name: polyacrylamide / C13-14 isoparaffin / Laureth 7) or Simulgel 600 (CTFA name: acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80) by the Seppic company; polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid, optionally crosslinked and / or neutralized, such as poly (2-acrylamido-2-methylpropanesulphonic acid) sold by the company Hoechst under the trademark "Hostacerin AMPS ° (CTFA name: ammonium polyacryloyldimethyl taurate or SIMULGEL 800® marketed by the company SEPPIC (CTFA name: sodium polyacryolyldimethyl taurate / polysorbate 80 / sorbitan oleate); copolymers of 2-acrylamido-2-methylpropanesulfonic acid and hydroxyethyl acrylate) such as SIMULGEL NS® and SEPINOV EMT 10® marketed by the company SEPPIC, cellulose derivatives such as hydroxyethylcellulose, polysaccharides and especially gums such as Xanthan gum, water-soluble or water-dispersible silicone derivatives such as acrylic silicones, polyether silicones and cationic silicones and mixtures thereof. Examples include, for example, inorganic or organic acids such as hydrochloric acid, orthophosphoric acid, sulfuric acid, carboxylic acids such as acetic acid, tartaric acid, citric, lactic acid, sulfonic acids. Among the alkalinizing agents that may be mentioned, for example, are ammonia, alkaline carbonates, alkanolamines such as mono-, di- and triethanolamines and their derivatives, sodium or potassium hydroxides. Preferably, the cosmetic composition comprises one or more alkalinizing agents chosen from alkanolamines, in particular triethanolamine, and sodium hydroxide. In the case of a direct emulsion, the pH of the composition according to the invention is generally between 3 and 12 approximately, preferably between 5 and 11 approximately, and even more particularly from 6 to 8.5. Among the active ingredients for the care of keratin materials such as the skin, the lips, the scalp, the hair, the eyelashes or the nails, mention may be made, for example: vitamins and their derivatives or precursors, alone or in mixtures the antioxidants; Anti-free radical agents; anti-pollutants, self-tanning agents, anti-glycation agents; soothing agents, deodorant agents essential oils, NO-synthase inhibitors; agents stimulating the synthesis of dermal or epidermal macromolecules and / or preventing their degradation; Agents stimulating the proliferation of fibroblasts; agents stimulating the proliferation of keratinocytes; - muscle relaxants, - cooling agents, - tensing agents, - mattifying agents, - depigmenting agents - pro-pigmenting agents - keratolytic agents, - desquamating agents; moisturizing agents, anti-inflammatory agents; antimicrobial agents, slimming agents, agents acting on the energetic metabolism of cells, insect repellents, P-substance antagonists or CRGPs. - anti-hair loss agents - anti-wrinkle agents, - anti-aging agents. The skilled person will choose the active agent (s) depending on the desired effect on the skin, hair, eyelashes, eyebrows, nails.

Of course, those skilled in the art will take care to choose the optional additional compound (s) mentioned above and / or their amounts in such a way that the advantageous properties intrinsically attached to the compositions in accordance with the invention are not, or substantially, not, altered by the addition or additions envisaged.

GALENIC FORMS The compositions according to the invention may be prepared according to the techniques well known to those skilled in the art. They may be in particular in the form of an emulsion, simple or complex (O / W, W / O, O / W / H or W / O / W) such as cream, milk or cream gel . They can also be in anhydrous form, such as in the form of an oil. The term "anhydrous composition" means a composition containing less than 1% by weight of water, or even less than 0.5% of water, and especially free of water, the water not being added during the preparation of the composition but corresponding to the residual water provided by the mixed ingredients. They may optionally be packaged in aerosol and be in the form of foam or spray.

In the case of compositions in the form of oil-in-water or water-in-oil emulsions, the emulsification processes that can be used are of the pale type or helix, rotor-stator and HHP type.

In order to obtain stable emulsions with a low level of polymer (oil / polymer ratio> 25), it is possible to disperse in the concentrated phase and then to dilute the dispersion with the rest of the aqueous phase.

It is also possible, by HHP (between 50 and 800b), to obtain stable dispersions with drop sizes up to 100 nm. The emulsions generally contain at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture. The emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W). Preferably, the compositions according to the invention are in the form of an oil-in-water or water-in-oil emulsion. The emulsifying surfactants are suitably selected according to the emulsion to be obtained. Non-limiting examples of emulsifying W / O surfactants suitable for water-in-oil emulsions are especially given in the book Mc Cutcheon's Emulsifiers & Detergents, 1998 International Edition. , MC Publishing Company, chapter HLB Index. As examples of W / O emulsifying surfactants, mention may be made of alkyl esters or ethers of sorbitan, glycerol, polyol, glycerol or sugars; silicone surfactants such as dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name "DC 5225 C®" by the company Dow Corning, and the alkyl-dimethicone copolyols such as Laurylmethicone copolyol sold under the name " Dow Corning 5200 Formulation Aid "by Dow Corning; cetyl dimethicone copolyol such as the product sold under the name Abil EM 90R® by the company Goldschmidt and the mixture of cetyl dimethicone copolyol, polyglycerol isostearate (4 moles) and hexyl laurate sold under the name ABIL WE 09 ® by the company Goldschmidt. It is also possible to add one or more coemulsifiers, which advantageously may be chosen from the group comprising the alkylated polyol esters.

Mention may also be made of non-silicone emulsifying surfactants, in particular alkyl esters or sorbitan, glycerol, polyol or sugar ethers. Alkyl polyol esters that may be mentioned in particular include polyethylene glycol esters such as PEG-30 dipolyhydroxystearate, such as the product. marketed under the name Arlacel P135® by the company ICI. Examples of glycerol and / or sorbitan esters that may be mentioned are polyglycerol isostearate, such as the product sold under the name Isolan GI 34® by the company Goldschmidt; sorbitan isostearate, such as the product sold under the name Arlacel 987® by the company ICI; sorbitan isostearate and glycerol, such as the product sold under the name Arlacel 986® by the company ICI, and mixtures thereof.

For O / W emulsions, mention may be made, for example, of nonionic emulsifying surfactants of polyoxyalkylenated fatty acid and glycerol esters (more particularly polyoxyethylenated and / or polyoxypropylenated); oxyalkylenated fatty acid and sorbitan esters; esters of polyoxyalkylenated fatty acids (in particular polyoxyethylenated and / or polyoxypropylenated) optionally in combination with a fatty acid and glycerol ester, such as the PEG-100 Stearate / Glyceryl Stearate mixture marketed for example by the company ICI under the name Arlacel 165; oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; fatty alcohol and sugar ethers, especially alkylpolyglucosides (APG) such as decylglucoside and laurylglucoside sold, for example, by Henkel under the respective names Plantaren 2000® and Plantaren 1200®, cetostearylglucoside, optionally in admixture with cetostearyl alcohol, sold for example under the name Montanov 68® by Seppic under the name Tegocare CG90® by Goldschmidt and under the name Emulgade KE3302® by Henkel, and arachidyl glucoside, for example under the name form of the mixture of arachidic and behenic alcohols and arachidylglucoside sold under the name Montanov 202® by the company Seppic. According to one particular embodiment of the invention, the mixture of the alkylpolyglucoside as defined above with the corresponding fatty alcohol may be in the form of a self-emulsifying composition, as described, for example, in WO- A-92/06778.

In a particularly preferred form, the compositions are in oil-in-water form. In the case of an emulsion, the aqueous phase thereof may comprise a nonionic vesicular dispersion prepared according to known methods (Bangham, Standish and Watkins, J. Mol Biol 13, 238 (1965)). FR 2 315 991 and FR 2 416 008). The compositions according to the invention find their application in a large number of treatments, in particular cosmetics, of the skin, lips and hair, including the scalp, in particular for the protection and / or care of the skin, lips and / or hair, and / or for makeup of the skin and / or lips. Another object of the present invention is constituted by the use of the compositions according to the invention as defined above for the manufacture of products for the cosmetic treatment of the skin, lips, nails, hair, eyelashes, eyebrows and / or scalp, including skincare products, sunscreen products and make-up products.

The cosmetic compositions according to the invention may for example be used as a makeup product. Another object of the present invention is constituted by a non-therapeutic cosmetic process for the care and / or makeup of a keratinous material consisting in applying to the surface of said keratinous material at least one composition according to the invention as defined herein. -above. The cosmetic compositions according to the invention may for example be used as a skincare and / or sun protection product for the face and / or the body of liquid to semi-liquid consistency, such as milks, more or less unctuous creams, gel-creams, pasta. They may optionally be packaged in aerosol and be in the form of foam or spray. The compositions according to the invention in the form of vaporizable fluid lotions according to the invention are applied to the skin or the hair in the form of fine particles by means of pressurizing devices. The devices according to the invention are well known to those skilled in the art and include non-aerosol pumps or "atomizers", aerosol containers comprising a propellant and aerosol pumps using compressed air as a propellant. These are described in US Pat. Nos. 4,077,441 and 4,850,517. The aerosol-conditioned compositions in accordance with the invention generally contain conventional propellants such as, for example, hydrofluorinated compounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane and trichlorofluoromethane. They are present preferably in amounts ranging from 15 to 50% by weight relative to the total weight of the composition.

In another aspect, the invention also relates to a cosmetic assembly comprising: i) a container delimiting one or more compartments (d), said container being closed by a closure element and possibly being unsealed; and ii) a make-up and / or care composition according to the invention disposed inside said compartment (s). The container may for example be in the form of a pot or a housing.

The closure member may be in the form of a cover comprising a cover mounted displaceable by translation or by pivoting relative to the container housing the one or more makeup compositions and / or care.

The examples which follow serve to illustrate the invention without, however, being limiting in nature. In these examples, the amounts of the ingredients compositions are given in% by weight relative to the total weight of the composition.

Example A1: Preparation of compound (1) (1) H 0 122.23 grams of 3 - [(3-methoxypropyl) amino] -2-cyclohexen-1-one were alkylated with dimethylsulphate or alternatively with diethylsulfate and treated with 75.45 grams of ethyl cyanoacetate in approximately equimolar proportions in the presence of a base and optionally a solvent. The following base / solvent combinations are used: Example Solvent base Example A1.1 DBU (1,8-diazabicyclo [5.4.0] undec-7-dimethylacetam ide ene) Example A1.2 triethylamine isopropanol Example A1.3 3-methoxypropylamine isopropanol Example A1.4 3-Methoxypropylamine tert-amylalcohol Example A1.5 3-methoxypropylamine toluene Example A1.6 3-methoxypropylamine dimethylformamide Example A1.7 3-methoxypropylamine without solvent Example A1.8 N-morpholine isopropanol The completion of the reaction Alkylation could be followed for example by methods such as TLC, GC or HPLC. 162.30 grams of compound (14) was obtained as a brown oil. After crystallization, the product is obtained in the form of yellowish crystals.

Melting point: 92.7 ° C.

Example A2: Preparation of Compound (2) H (2) 0 No 148.4 grams of 3 - [(3-methoxypropyl) amino] -2-cyclohexen-1-one were alkylated with dimethylsulphate or alternatively with diethylsulfate and treated with 130.00 grams of 2-ethoxyethyl cyanoacetate in the presence of an organic base and a solvent. The following base / solvent combinations were used: Example Solvent Base Example A2.1 DBU (1,8-diazabicyclo [5.4.0] undet dimethylacetamide 7-ene) Example A2.2 triethylamine isopropanol Example A2.3 3-methoxypropylamine isopropanol Example A2.4 N-methylmorpholine tert-amylalcohol Example A2.5 3-Methoxypropylamine toluene Example A2.6 3-Methoxypropylamine dimethylformamide Example A2.7 3-methoxypropylamine Without solvent Example A3 (except invention): Preparation of compound (2Z) 2-cyano-N- (3-methoxy-propyl) -2- {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanamide described in PCT / EP2012 / 064195 unpublished H 0 N 101.00 grams of 3 - [(3-methoxypropyl) amino] -2-cyclohexen-1-one were alkylated with dimethylsulfate or alternatively with diethylsulfate and treated with 86.00 grams of 2-cyano-N- (3- methoxy-propyl) -acetamide in approximately equimolar proportions in the presence of a base and optionally a solvent.

The following base / solvent combinations were used: Example Solvent Base Example A3.1 DBU (1,8-diazabicyclo [5.4.0] undec-7-dimethylacetam ideene) Example A3.2 triethylamine isopropanol Example A3.3 3- Methoxypropylamine isopropanol Example A3.4 3-Methoxypropylamine tert-amylalcohol Example A3.5 3-methoxypropylamine toluene Example A3.6 3-methoxypropylamine dimethylformamide Example A3.7 3-methoxypropylamine without solvent The crude product (2Z) -2-cyano-N (3-methoxy-propyl) -2- {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanamide was obtained as a dark brown oil.

After column chromatography on silica gel (eluent: 99/1 toluene / methanol), 81.8 grams of product were obtained as yellowish crystals. Melting point: 84.7-85.3 ° C.

Examples of formulations 1 to 4 The 2-ethoxyethyl (2Z) -cyano {3 - [(3-methoxypropyl) -amino] -cyclohex-2-en-1-ylideneethanoate (2) compound of the invention was compared with to the compound (2Z) -2-cyano-N- (3-methoxy-propyl) -2- {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanamide according to the example A3 (Excluding the Invention) - the compound octyl-5-N, N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate (ex-invention) The following formulas 1-4 were prepared; they have been constructed so that the sum of the oil and UV-soluble filter levels remains constant. The filter rate is adjusted to ensure the same level of UVB filtration and thus the same SPF in vitro, as well as the same absorbance profile between 290 and 340nm. For each of the formulas, SPF, UVApp0, and absorbance were measured after 24 hours at room temperature. The amounts are expressed in% by weight relative to the total weight of the composition. Phase Ingredients Formula 1 Formula 2 (excluding (except invention) invention) A Water QSP 100 QSP 100 Glycerin 6 6 Disodium EDTA 0.1 0.1 Triethanolamine 0.45 0.45 Methylene Bis-Benzotriazolyl 5% 5% Tetramethylbutylphenol Material Active Ingredient (Tinosorb M®) Potassium Cetyl Phosphate 1 1 (Amphisol KC)) B 2-Ethylphenyl Benzoate 29.4 (X-Tend 226®) Octy1-5-N, N-diethylamino-2- - O, 6 phenysulfony1-2,4-pentadienoate Stearic Acid 1,5 1,5 Glyceryl Stearate (and) PEG-1,500 Stearate (Arlacel 165 (D) 1 Dimethicone 0.5 0.5 Preservatives 1.28 1.28 C Isohexadecane 2 2 Xanthan gum 0.1 0.1 Acrylates / C10-30 Alkyl 0.25 0.25 Acrylate crosspolymer (Pemulen TRI ()) D Triethanolamine 0.25 0.25 E Alcohol 2 2 SPF in vitro (t24h) 4 , 1 ± 0.3 3.8 ± 0.2 UVA ppD in vitro (t2e) 4.5 ± 0.3 6.7 ± 0.5 Phase Ingredients Formula 3 Formula 4 (excluding (invention) invention) A Water QSP 100 QSP 100 Glycerin 6 6 Disodium EDTA 0.1 0.1 Triethanolamine 0.45 0.45 Methylene Bis-Benzotriazolyl 5 5 Tetram ethylbutylphenol (Tinosorb M®% active ingredient) Potassium Cetyl 1 1 Phosphate (Amphisol K®) B 2-Ethylphenyl benzoate 29.2 29 (X-Tend 226®) (2Z) -2-cyano-N- (3- 0.8 - methoxypropyl) -2- {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenelethanam ide Compound (2) - 1 Stearic acid 1.5 1.5 Glyceryl Stearate (and) PEG- 1 5 100 Stearate (Arlacel 165®) 1 5 Dimethicone 0.5 0.5 Preservatives 1.28 1.28 C Isohexadecane 2 2 xanthan gum 0.1 0.1 Acrylates / C10-C30 Alkyl 0.25 0 , 25 Acrylate crosspolymer (Pemulen TRI ()) D Triethanolamine 0.25 0.25 E Alcohol 2 2 SPF in vitro (t24h) 4.1 ± 0.1 4.1 ± 0.3 UVA PPD in vitro (t24h) 7 , 2 ± 0.3 7.4 ± 0.8 Method of preparing the emulsions: The aqueous A and oily B phases were prepared by mixing the raw materials with mechanical stirring at 80 ° C. Once aqueous A and oily B solutions were macroscopically homogeneous, the emulsion was prepared by introducing phase B into phase A with stirring using a rotor-stator homogenizer under one speed. stirring of 4500 RPM for 20 minutes. Still under stirring, the phases C and D were then successively added. The emulsion was finally cooled to room temperature. The final emulsion was characterized by drops of size between 1 μm and 20 μm.

Protocol for In Vitro Evaluation of Filter Efficiency The sun protection factor (SPF) was determined according to the "in vitro" method described by B. L. Diffey in J. Soc. Cosmet. Chem. 40, 127-133, (1989). The measurements were carried out using a UV-1000S spectrophotometer from the company Labsphere. The value "In Vitro Protection Factor (SPF)" is extracted. Each composition is applied to a rough plate of PMMA, in the form of a homogeneous and regular deposit at a rate of 1 mg / cm 2. The measurements of the UVAppp index in vitro were made under the same conditions using a UV-1000S spectrophotometer from the company Labsphere. The value "UV-A Index ppD (Action Spectrum Persistent Pigment Darkening)" is extracted. Each composition was applied to a rough PMMA plate, in the form of a homogeneous and regular deposit at a rate of 1 mg / cm 2.

Absorbance Spectrometry Evaluation Protocol of the Formulas Absorbance spectra of the formulas were extracted from mAF data as a function of wavelength generated during measurement of in vitro SPF and in vitro PPD. The mAF values are then converted to Absorbance according to: Abs = log (mAF). Profiles can be normalized to 320nm. Absorbance profiles of formulas measured 24 hours after formulation Absorbance Formula 1 Formula 2 Formula 3 Formula 4 (invention) (off (off (outside invention) invention) invention) Absorbance at 290 nm after 24 hours Absorbance at 320 nm after 24 hours Absorbance at 400 nm after 24 hours 0.61 ± 0.02 0.57 ± 0.03 0.59 ± 0.01 0.58 ± 0.03 0.60 ± 0.03 0.56 ± 0.02 0.60 ± 0 , 01 0.59 ± 0.04 0.24 ± 0.01 '0.28 ± 0.01 0.54 ± 0.01 0.65 ± 0.04 Conclusions The in vitro UVAppp index values of the formula 1 show that for the same SPF and a similar absorbance profile in the UVB, from 290 to 320 nm (formula 2), the Tinosorb M® alone is less protective than the Tinosorb M® / Merocynanine combinations (Formulas 2,3 and 4 ). The Tinosorb M® / Compound 2 (Formula 4) combination of the invention is distinguished from the Tinosorb M® / Octy1-5-N, N-diethylamino-2-phenylsulfonyl-2,4-pentadienoate (Formula 2) and Tinosorb couples. M? / (2Z) -2-cyano-N- (3-methoxypropyl) -2- {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidenel-ethanam ide (Formula 3) by a broader absorbance profile in UVA and a significantly higher absorbance at 400nm for comparable in vitro SPF and UVAppD.

Claims (18)

REVENDICATIONS1. Cosmetic or dermatological composition comprising in a physiologically acceptable support: a) at least one oily phase and b) at least one merocyanine compound corresponding to the following formula (1) and its isomeric E / E- or E / Z- geometrical forms: (1) H in which R is a C1-C22 alkyl group, a C2-C22 alkenyl group, a C2-C22 alkinyl group, a C3-C22 cycloalkyl group or a C3-C22 cycloalkenyl, said groups being capable of be interrupted by one or more O and c) at least one insoluble organic UV filter. 2. Composition according to claim 1, wherein the merocyanine compound (s) of formula (1) are chosen from those in which R is a C 1 -C 22 alkyl which may be interrupted by one or more O. 3. Composition according to claim 1 or 2, wherein the merocyanine compound (s) of formula (1) are chosen from the following compounds as well as their isomeric geometrical forms E / E-, E / Z-: 1 0 0 4 H ol oo NH 2 (2Z) -cyano (3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-one Ylidene} ethanoate-N, N-butoxyethyl (2Z) -cyano {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidene} ethanoate 2 0.05 (bo oo HH (1) N on N-2-ethoxyethyl (2Z) -cyano {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidene} ethanoate N 3 -methoxypropyl (2Z) -cyano {3 - [(3-methoxypropyl) ) amino] cyclohex-2-en-1-ylidene} ethanoate ## STR1 ## 3-ethoxypropyl (2Z) -cyano (3 - [(3-methoxypropyl) amino] cyclohexyl 2-en-1-ylidene} ethanoate 2-methylpropyl (2Z) -cyano {3 - [(3-methoxypropyl) amino] cyclohex-2-en-1-ylidene} ethanoate The composition according to claim 3, wherein the merocyanine compound is 2-ethoxyethyl (2Z) -cyano {3 - [(3-methoxypropyl) -amino] cyclohex-2-en-1-ylideneethanoate (2) in its Geometric configuration E / Z of following structure: HN and / or in its geometric E / E configuration of following structure: oJ H 0 NO 5. Composition according to any one of claims 1 to 4, wherein the merocyanine compound (s) of formula (1) are present in a concentration ranging from 0.1% to 10% by weight, and preferably from 0.2% to 5% by weight relative to the total weight of the composition. 6. Composition according to any one of claims 1 to 5, wherein the insoluble organic UV filter is in the form of particles of average size ranging from 0.01 to 5pm and more preferably from 0.01 to 2 pm and more particularly 0.020. at 2 pm. 7. Composition according to any one of claims 1 to 6, wherein the insoluble organic UV filter is chosen from organic UV filters of oxalanilide type, triazine type, benzotriazole type; vinyl amide type; of the cinnamide type; of the type comprising one or more benzazole and / or benzofuran, benzothiophene or indole groups; aryl vinylene ketone type; phenylene bis-benzoxazinone derivative type, amide derivative type, sulfonamide or acrylonitrile carbamate or mixtures thereof. 8. Composition according to any one of claims 1 to 7, wherein the insoluble organic UV filter is chosen from: (i) symmetrical triazines substituted by naphthalenyl groups or polyphenyl groups, in particular 2,4,6-tris ( di-phenyl) -triazine and / or 2,4,6-tris (ter-phenyl) -triazine; (ii) the methylene bis- (hydroxyphenylbenzotriazole) compounds of formula (IV) below: (IV) T ii in which the radicals T10 and T11, which may be identical or different, denote a C 1 -C 18 alkyl radical which may be substituted with one or a plurality of radicals selected from C1-C4alkyl, C5-C12cycloalkyl or aryl radical; (iii) and mixtures thereof. 9. Composition according to claim 8, wherein the methylene bis (hydroxyphenyl benzotriazole) compound of formula (IV) is in the form of an aqueous dispersion of particles of average particle size which varies from 0.01 to 5 μm, and more preferably from 0, 0.1 to 2 μm, and more particularly 0.020 to 2 μm, in the presence of at least one surfactant of structure CnH2r1-0O (C61-11005) xH in which n is an integer of 8 to 16 and x is the average degree of polymerization of the unit (C6H1005) and varies from 1.4 to 1.6. 10. Composition according to claim 8 or 9, wherein the methylene bis (hydroxyphenyl benzotriazole) compound of formula (IV) is in the form of an aqueous dispersion of particles of average size ranging from 0.02 to 2 μm, and more preferably from 0.01 to at 1.5 μm, and more particularly from 0.02 to 1 μm in the presence of at least one mono- (C 8 -C 20) alkyl polyglycerol ester having a glycerol polymerization degree of at least 5. 11. Composition according to claim 10, wherein the mono- (C8-C20) alkyl polyglycerol ester is selected from decaglyceryl caprate, decaglyceryl laurate, decaglyceryl myristate, decaglyceryl oleate, decaglyceryl stearate. decaglyceryl isostearate, hexaglyceryl caprate, hexaglyceryl laurate, hexaglyceryl myristate, hexaglyceryl oleate, hexaglyceryl stearate, hexaglyceryl isostearate, pentaglyceryl caprate, pentaglyceryl laurate, pentaglyceryl myristate, pentaglyceryl oleate, pentaglyceryl stearate, pentaglyceryl isostearate and more particularly from decaglyceryl caprate and decaglyceryl laurate. OH CH2 12. Composition according to claim 10 or 11, wherein the amount of methylene bis- (hydroxyphenylbenzotriazole) compound of formula (IV) in the aqueous dispersion varies from 10 to 50% by weight, and more preferably from 30 to 50% by weight. relative to the total weight of the dispersion. 13. Composition according to any one of claims 10 to 12, wherein the ratio by weight compound methylene bis- (hydroxyphenyl benzotriazole) / mono- (C8-C20) alkyl polyglycerol varies from 0.05 to 0.5, and more preferably from 0.1 to 0.3. A composition according to any one of claims 9 to 13, wherein the methylene bis (hydroxyphenyl benzotriazole) compound of formula (IV) in the form of an aqueous dispersion is the compound 2,2'-methylene-bis- [6- ( 2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol having the following structure: compound (a) 15. Composition according to any one of claims 1 to 13, wherein the insoluble organic UV filter (s) of the invention are present at a concentration of active material ranging from 0.1 to 15% by weight, and more particularly from 0 to 5 to 10% by weight relative to the total weight of the composition. 16. Non-therapeutic cosmetic process for the care and / or makeup of a keratinous material comprising the application on the surface of said keratinous material of at least one composition as defined in any one of the preceding claims. 17. Non-therapeutic cosmetic process for limiting the darkening of the skin and / or improving the color and / or the uniformity of the complexion, comprising the application on the skin surface of at least one composition as defined in any one of the preceding claims. 18. A non-therapeutic cosmetic method for preventing and / or treating the signs of aging of a keratinous material comprising the application on the surface of the keratinous material of at least one composition as defined in any one of the claims. preceding. 10